JMIR Publications

ABSTRACT

Background:

Human Papilloma Virus (HPV) is one of the most prevalent sexually transmitted infections in the U.S., however vaccination uptake falls far below the goal of 80% of the population set forth by Healthy People 2030. Specifically, within the LGBTQ+ population, HPV vaccination adherence remains a complex issue. Due to the widespread use of technology within the young adult population, digital health tools such as digital storytelling have been promoted as an effective way to increase vaccination uptake.

Objective:

The purpose of this study was to conduct a formative inquiry into (1) what components should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations? And (2) What dissemination channels would be more effective and impact the uptake and completion of the HPV vaccine among sexual and gender minority populations? Additionally, this study aims to provide insight into perceived HPV risk and its implications on the HPV vaccine uptake within the LGBTQ+ population.

Methods:

A mixed methods study was conducted between January 2021- September 2021 in Atlanta, Georgia. Intake surveys were distributed to individuals identifying as members of the LGBTQ+ community to examine demographic characteristics, barriers to vaccine adherence and current HPV vaccination status. Key informant interviews were conducted via Zoom with participants who completed the intake surveys and consented to be interviewed. Transcripts were coded and analyzed using the constant comparison method, for emergent themes surrounding components of effective digital storytelling campaigns.

Results:

Perceived HPV risk was assessed using 5 statements on a 1 to 7 Likert scale. 13 out of 47 (27.7%) of participants indicated that they were not sure when provided with the statement “I am likely to get HPV”. 12 out of 47 (29.8%) strongly disagreed with the statement “I am at high risk for getting HPV” and 13 out of 47 (27.7%) indicated that they were not sure when presented with the statement “HPV would be a serious threat to the quality of my life”. 14 out of 47 (29.8%) responded not sure to the statement “HPV would be a severe threat to my health” and 13 out of 47(27.7%) strongly agreed that “HPV would be a severe threat to my sex life”. Qualitative analysis indicated high level of stigma experienced in interactions between the LGBTQ+ population and private practitioners. Major barriers to vaccination hesitancy were concerns about age, perceived reduced risk and lack of provider recommendation. Participant interviews revealed that “Real Outcomes”, and “Accurate Representation” were the main components that should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations.

Conclusions:

Creation of a digital storytelling intervention within the LGBTQ+ population should include information surrounding real outcomes of HPV and accurate representation.